These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Approved monoclonal antibodies for cancer therapy. Boyiadzis M; Foon KA Expert Opin Biol Ther; 2008 Aug; 8(8):1151-8. PubMed ID: 18613766 [TBL] [Abstract][Full Text] [Related]
3. [An overview of antibody therapy against cancer]. Taniguchi H; Imai K Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378 [TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibody for cancer treatment]. Achiwa H; Sato S; Ueda R Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531 [TBL] [Abstract][Full Text] [Related]
5. EGFR targeting of solid tumors. Rocha-Lima CM; Soares HP; Raez LE; Singal R Cancer Control; 2007 Jul; 14(3):295-304. PubMed ID: 17615536 [TBL] [Abstract][Full Text] [Related]
6. Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies. Gialeli Ch; Kletsas D; Mavroudis D; Kalofonos HP; Tzanakakis GN; Karamanos NK Curr Med Chem; 2009; 16(29):3797-804. PubMed ID: 19747140 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies as therapeutics in human malignancies. Pandey M; Mahadevan D Future Oncol; 2014 Mar; 10(4):609-36. PubMed ID: 24754592 [TBL] [Abstract][Full Text] [Related]
9. Comparing antibody and small-molecule therapies for cancer. Imai K; Takaoka A Nat Rev Cancer; 2006 Sep; 6(9):714-27. PubMed ID: 16929325 [TBL] [Abstract][Full Text] [Related]
10. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Shih T; Lindley C Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999 [TBL] [Abstract][Full Text] [Related]
11. Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics. Runcie K; Budman DR; John V; Seetharamu N Mol Med; 2018 Sep; 24(1):50. PubMed ID: 30249178 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic Antibodies in Cancer Therapy. Gasser M; Waaga-Gasser AM Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554 [TBL] [Abstract][Full Text] [Related]
13. Tumor-targeted and immune-targeted monoclonal antibodies: Going from passive to active immunotherapy. Marabelle A; Gray J Pediatr Blood Cancer; 2015 Aug; 62(8):1317-25. PubMed ID: 25808079 [TBL] [Abstract][Full Text] [Related]
14. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415. Adis International Ltd Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590 [TBL] [Abstract][Full Text] [Related]
15. Antibody-based therapy for solid tumors. Yan L; Hsu K; Beckman RA Cancer J; 2008; 14(3):178-83. PubMed ID: 18536557 [TBL] [Abstract][Full Text] [Related]
16. Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update. Eyvazi S; Farajnia S; Dastmalchi S; Kanipour F; Zarredar H; Bandehpour M Curr Cancer Drug Targets; 2018; 18(9):857-868. PubMed ID: 29295696 [TBL] [Abstract][Full Text] [Related]
17. Anticancer antibodies. Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120 [TBL] [Abstract][Full Text] [Related]